Genomic analysis
Ended Purchase Order Awarded Last action
- Contract number
- N0018924PZ276
- Awardee
-
Pathoseq Bio, LLC UEI XZBGAKEK7K55
- Awarding agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Obligated
- $155,106
Award facts
- Contract value 100% obligated
- $155,106.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Bureau of Medicine and Surgery Department of the Navy, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- United States Minor Outlying Islands
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $19,349 | |
| Original award | $135,757 |
About this award
The U.S. Department of the Navy's Bureau of Medicine and Surgery awarded a $155,106 firm fixed-price purchase order to Pathoseq Bio, LLC for genomic analysis services. This contract, designated as a Total Small Business set-aside, was awarded on July 9, 2024, with an ultimate completion date of March 31, 2025. Pathoseq Bio, a small business based in Omaha, Nebraska, specializes in advanced genomic analysis and biothreat detection using its proprietary Pan-Viral Panel technology compatible with Oxford Nanopore Technologies MinION sequencing devices. The place of performance is designated as the United States Minor Outlying Islands.
This contract represents one of three recent awards to Pathoseq Bio from the Navy's Bureau of Medicine and Surgery, reflecting the contractor's established capabilities in supporting the Department of the Navy's medical research and biosurveillance objectives. The genomic analysis services align with the Navy's broader mission to enhance infectious disease surveillance and biothreat detection capabilities across its medical research networks. As a firm fixed-price contract with small business set-aside status, this award demonstrates the government's commitment to leveraging specialized small business expertise in critical biosurveillance and medical research applications.
Quick answers
Who was awarded contract N0018924PZ276?
N0018924PZ276 was awarded to Pathoseq Bio, LLC by Naval Supply Systems Command (Department of the Navy) on July 9, 2024.
How much is contract N0018924PZ276 worth?
The government has obligated $155,106 on N0018924PZ276.
Which agency awarded contract N0018924PZ276?
Naval Supply Systems Command (Department of the Navy) awarded N0018924PZ276, with funding from Bureau of Medicine and Surgery (Department of the Navy).
Was contract N0018924PZ276 competed?
The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award